Course Director Paul Teirstein MD, DNBPAS, FACC, FSCAI is shown using a Geiger counter during the 33rd Annual Cardiovascular Interventions last month in La Jolla, CA demonstrating Rampart’s radiation attenuation efficacy. In the discussion, Dr. Teirstein explains how Rampart addresses two key factors that can affect a cath lab team’s daily performance and career longevity: radiation exposure and the physical burden of wearing protective lead.
It is wonderful to see Rampart in live cases at the symposium, protecting interventionalists and their teams as they care for patients. We applaud Dr. Teirstein, an early Rampart adopter, and these panelists, for their efforts to challenge institutions and colleagues to adopt potentially career-saving technologies sooner rather than later.
Direct link to video transcript here:
www.rampartic.com/news/2022/1...